3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acton, EM; Brown, BW; Ehsan, MN; Friend, NF; Hacker, MP; Harker, WG; Newman, RA; Sikic, BI | 1 |
1 other study(ies) available for 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and Breast Cancer
Article | Year |
---|---|
Dissociation of antitumor potency from anthracycline cardiotoxicity in a doxorubicin analog.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Doxorubicin; Female; Heart; Humans; Isoenzymes; L-Lactate Dehydrogenase; Mice; Myocardium; Ovarian Neoplasms; Pregnancy | 1985 |